Buscar
Mostrando ítems 1-10 de 55
Pirfenidone gel in patients with localized scleroderma: a phase II study
(BioMed Central, 2020)
Localized scleroderma: assessment of the therapeutic response to phototherapyEsclerodermia cutânea: avaliação da resposta terapêutica à fototerapia
(Sociedade Brasileira de Dermatologia, 2012)
BACKGROUND: Scleroderma is a chronic autoimmune disease characterized by progressive connective tissue sclerosis and microcirculatory changes. Localized scleroderma is considered a limited disease. However, in some cases ...
Neuroimaging findings in scleroderma en coup de sabre
(Lippincott Williams & WilkinsPhiladelphiaEUA, 2004)
Juvenile localized scleroderma: Clinical and epidemiological features in 750 children. An international study
(2006-05-01)
Objective. Juvenile localized scleroderma (JLS) includes a number of conditions often grouped together. With the long-term goal of developing uniform classification criteria, we studied the epidemiological, clinical and ...
Juvenile localized scleroderma: Clinical and epidemiological features in 750 children. An international study
(2006-05-01)
Objective. Juvenile localized scleroderma (JLS) includes a number of conditions often grouped together. With the long-term goal of developing uniform classification criteria, we studied the epidemiological, clinical and ...
Type 1 IFN-induced protein MxA and plasmacytoid dendritic cells in lesions of morphea
(WILEY-BLACKWELL, 2012)
Morphea is an autoimmune sclerotic skin disease of unknown pathogenesis. As type 1 interferons (IFN) have been implicated in the pathogenesis of systemic sclerosis, we proposed that type 1 IFN promote localized inflammation ...